$TBRG

Wilson Merideth sold (to issuer) $203K of TBRG

Wilson Merideth (Financial Health GM) sold (to issuer) 12,042 shares of TruBridge, Inc. (TBRG) at $26.25 ($0.20M total) across 2 trades on 2026-07-09.

Original reporting
SEC EDGAR · Wilson Merideth
Published Jul 10, 2026, 2:40 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 10, 2026, 2:42 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TBRG
Neutral
high confidence
Mentioned
$TBRG
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TBRGNeutralLow
01

Why it matters

The disclosed event is an officer sale to the issuer at a stated price for one of the trades, with no accompanying company-specific news (earnings, guidance, contracts, litigation, or financing) in the text.

02

Market read

Traders may note the insider sale, but the filing does not introduce new fundamental information that would typically drive repricing.

03

What to watch

The article does not disclose the first trade’s price, the rationale for the sale, or whether it is part of compensation/tax mechanics; those details can materially change interpretation.

Relevance 4/10Novelty 3/10Timing: Filed 2026-07-10 after the 2026-07-09 insider sale to the issuer.

Background

The article is an SEC Form 4 insider transaction disclosure for TruBridge, Inc. (TBRG).

Company-level read

Ticker impact

$TBRGNeutralHigh confidence
Context

TruBridge Form 4 shows officer Wilson Merideth sold 12,042 shares to the issuer at $26.25 on 2026-07-09, leaving 0 shares.

Expected impact

Likely minimal near-term impact; any effect is more about signaling than fundamentals.

Evidence & confidence

The filing is a routine insider transaction with no 10b5-1 plan and no accompanying company guidance, deal, or regulatory action in the text.

Market effects

No sector read-through is provided beyond a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Because the holdings after the transaction are 0 shares and there is no stated 10b5-1 plan, some traders may interpret it as stronger-than-usual insider confidence risk, even though the filing alone does not prove fundamentals changed.

Key entities

  • TruBridge, Inc.

    Company whose Form 4 insider transaction is disclosed.

  • Wilson Merideth

    Officer who sold shares to the issuer and reported holdings of 0 shares after the transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles